104 related articles for article (PubMed ID: 8172738)
1. Percutaneous ethanol injection therapy of adenomatous hyperplastic nodules in cirrhotic liver disease.
Lencioni R; Caramella D; Bartolozzi C; Mazzeo S; Di Coscio G
Acta Radiol; 1994 Mar; 35(2):138-42. PubMed ID: 8172738
[TBL] [Abstract][Full Text] [Related]
2. [Small nodules of adenomatous hyperplasia in the cirrhotic liver. Treatment with percutaneous alcoholization].
Lencioni R; Di Coscio G; Bagnolesi P; Cilotti A; Pinto F; Vignali C; Bartolozzi C
Radiol Med; 1992; 84(1-2):74-8. PubMed ID: 1509150
[TBL] [Abstract][Full Text] [Related]
3. Adenomatous hyperplastic nodules in the cirrhotic liver: a therapeutic approach. Work in progress.
Livraghi T; Sangalli G; Vettori C
Radiology; 1989 Jan; 170(1 Pt 1):155-7. PubMed ID: 2642340
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor in cirrhotic liver, adenomatous hyperplastic nodule and hepatocellular carcinoma in the human.
Nagasue N; Yamanoi A; Kohno H; Kimoto T; Chang Y; Taniura H; Uchida M; Nakamura T
Hepatogastroenterology; 1992 Oct; 39(5):455-60. PubMed ID: 1334038
[TBL] [Abstract][Full Text] [Related]
6. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
[TBL] [Abstract][Full Text] [Related]
7. Management of adenomatous hyperplastic nodules in the cirrhotic liver: US follow-up or percutaneous alcohol ablation?
Lencioni R; Bartolozzi C; Caramella D; Di Coscio G
Abdom Imaging; 1993; 18(1):50-5. PubMed ID: 8381690
[TBL] [Abstract][Full Text] [Related]
8. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
Vallone P; Catalano O; Izzo F; Siani A
Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
[TBL] [Abstract][Full Text] [Related]
9. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.
Kaji K; Terada T; Nakanuma Y
Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103
[TBL] [Abstract][Full Text] [Related]
10. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
[TBL] [Abstract][Full Text] [Related]
11. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
[TBL] [Abstract][Full Text] [Related]
13. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Nakanuma Y; Terada T; Ida M
Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
[TBL] [Abstract][Full Text] [Related]
14. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results].
Bartolozzi C; Lencioni R; Armillotta N
Radiol Med; 1997; 94(1-2):19-23. PubMed ID: 9424645
[TBL] [Abstract][Full Text] [Related]
15. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates.
Castroagudín JF; Delgado M; Villanueva A; Bustamante M; Martínez J; Otero E; Tomé S; Martínez SM; Segade FR; Conde R; Dominguez-Muñoz E; Varo E
Transplant Proc; 2005 Nov; 37(9):3871-3. PubMed ID: 16386568
[TBL] [Abstract][Full Text] [Related]
16. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection.
Ishii H; Okada S; Okusaka T; Yoshimori M; Nakasuka H; Shimada K; Yamasaki S; Nakanishi Y; Sakamoto M
Cancer; 1998 May; 82(9):1638-42. PubMed ID: 9576282
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous ethanol injection (PEI) for small hepatocellular carcinoma].
Ebara M; Kita K; Nagato Y; Yoshikawa M; Sugiura N; Ohto M
Gan To Kagaku Ryoho; 1993 May; 20(7):884-8. PubMed ID: 8387759
[TBL] [Abstract][Full Text] [Related]
18. MR-guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation.
Blum M; Mueller C; Peck-Radosavljevic M; Wrba F; Berlakovich G; Mühlbacher F; Steiniger R; Speiser M; Pones M; Hüpfl M; Lammer J; Kettenbach J
Minim Invasive Ther Allied Technol; 2007; 16(4):230-40. PubMed ID: 17763097
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous alcohol administration for hepatocarcinoma: long-term results].
Lencioni R; Paolicchi A; Bartolozzi C
Radiol Med; 1997; 94(1-2):8-13. PubMed ID: 9424657
[TBL] [Abstract][Full Text] [Related]
20. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]